🇺🇸 FDA
Pipeline program

BHV-1300

BHV1300-202

Phase 1 small_molecule active

Quick answer

BHV-1300 for Graves Disease is a Phase 1 program (small_molecule) at Biohaven Bioscience Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Biohaven Bioscience Ireland Limited
Indication
Graves Disease
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials